Acetazolamide Is an Effective Adjunct for Urinary Alkalization in Patients With Uric Acid and Cystine Stone Formation Recalcitrant to Potassium Citrate

Urology

Volumn 72, Issue 2, 2008, Pages 278-281

  Sterrett, Samuel P ^a   Penniston, Kristina L ^a   Wolf Jr , J Stuart ^b   Nakada, Stephen Y ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALLOPURINOL; CAPTOPRIL; CITRATE POTASSIUM; PENICILLAMINE; TIOPRONIN;

ADULT; AGED; ARTICLE; BEDTIME DOSAGE; CLINICAL ARTICLE; CYSTINURIA; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL INTOLERANCE; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY CALCIFICATION; KIDNEY SURGERY; MALAISE; MALE; MORNING DOSAGE; NAUSEA; NOCTURIA; PARESTHESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENT DISEASE; UPPER EXTREMITY PARESTHESIA; URIC ACID STONE; URINE PH;

ACETAZOLAMIDE; ADULT; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; CYSTINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; POTASSIUM CITRATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URIC ACID; URINE;

EID: 48349132997     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.04.003     Document Type: Article

References (15)

1. Chow G.K., and Streem S.B. Medical treatment of cystinuria: Results of contemporary clinical practice. J Urol 156 (1996) 1576
2. Ng C.S., and Streem S.B. Contemporary management of cystinuria. J Endourol 13 (1999) 647
3. Barbey F., Joly D., Rieu P., et al. Medical treatment of cystinuria: Critical reappraisal of long-term results. J Urol 163 (2000) 1419-1423
4. Shekarriz B., and Stoller M.L. Uric acid nephrolithiasis: Current concepts and controversies. J Urol 168 (2002) 1307-1314
5. Dretler S.P., and Pfister R.C. Percutaneous dissolution of renal calculi. Annu Rev Med 34 (1983) 359-366
6. Dretler S.P. The physiologic approach to the medical management of stone disease. Urol Clin North Am 25 (1998) 613-623
7. Barbey F., Nseir G., Ferrier C., et al. Carbonic anhydrase inhibitors and calcium phosphate stones. Nephrologie 25 (2004) 169-172
8. Freed S.Z. The alternating use of an alkalizing salt and acetazolamide in the management of cystine and uric acid stones. J Urol 113 (1975) 96-99
9. Rubenstein M.A., and Bucy J.G. Acetazolamide induced renal calculi. J Urol 114 (1975) 610-612
10. Ahlstrand C., and Tiselius H.G. Urine composition and stone formation during treatment with acetazolamide. Scand J Urol Nephrol 21 (1987) 225-228
11. Paisley K.E., and Tomson C.R. Calcium phosphate stones during long-term acetazolamide treatment for epilepsy. Postgrad Med J 75 (1999) 427-428
12. Parikh J.R., and Nolan R.L. Acetazolamide-induced nephrocalcinosis. Abdom Imaging 19 (1994) 466-467
13. Tawil R., Moxley III R.T., and Griggs R.C. Acetazolamide-induced nephrolithiasis: Implications for treatment of neuromuscular disorders. Neurology 43 (1993) 1105-1106
14. Mogk L.G., and Cyrlin M.N. Blood dyscrasias and carbonic anhydrase inhibitors. Ophthalmology 95 (1988) 768-771
15. Woodbury D.M. Carbonic anhydrase inhibitors. Adv Neurol 27 (1980) 617-633